Author: Pooja Babbrah

Emerging NCPDP Standard Enhancements to Improve Speed to Therapy for Specialty Medications

By Pooja Babbrah, Practice Lead, PBM Services Specialty medications are changing health care, providing life-saving treatment options for patients with rare and chronic conditions.  Patients, however, often face big hurdles …

CARIN Alliance Workgroup to Help Advance Real-Time Pharmacy Benefit Check for Patients

By Pooja Babbrah, Practice Lead, PBM Services  The CARIN Alliance—a large, multi-stakeholder coalition–has formed a workgroup aimed at advancing the consumer-facing, real-time pharmacy benefit check (RTPBC). The goal is to …

Urgent Need for Real-Time Pharmacy Benefit Check Confirmed in Senate Committee Hearings

By Pooja Babbrah, PBM Services Practice Lead In mid-March, I was invited to testify in front of the U.S. Senate Special Committee on Aging at a hearing they held focused …

The Time is Right for Canada to Incorporate a Naming Convention for Biologics and Biosimilars into its Emerging ePrescribing Infrastructure

By Pooja Babbrah, Senior Consultant In January 2017, the Food and Drug Administration (FDA) released the Final Rule for Biosimilar Naming. In this final rule, the FDA spelled out the …

New NCPDP Specialty Pharmacy Workgroup to Meet on August 3

By Pooja Babbrah, Practice Lead, PBM Services NCPDP’s newly formed Work Group 18 on Specialty Pharmacy will hold its first meeting on August 3, 2018, in St. Louis. This is …

NCPDP To Consider Formation of Specialty Pharmacy Work Group

  By Pooja Babbrah, Practice Lead, PBM Services The move to automate and standardize specialty pharmacy transactions could take a big and necessary step forward if a new Specialty Pharmacy …

How Stakeholders are Affected by FDA’s New Naming Convention for Biologics and Biosimilars

By Pooja Babbrah, Senior Consultant Stakeholders across the industry are debating potential costs and burden associated with implementing the new, nonproprietary naming convention for biologics and biosimilars. Requirements for the …

Medication Non-Adherence: Is There an App for That?

By Pooja Babbrah, Senior Consultant  Getting patients to adhere to their medication regimen is a growing problem—and solutions are being sought. The reasons are compelling. Non-adherence to prescribed medications results in $100 to $300 billion in avoidable healthcare costs. A significant portion of …

FDA Issues Guidance on Naming Conventions and Interchangeability for Biologics and Biosimilars

By Pooja Babbrah, Senior Consultant The Food and Drug Administration (FDA) recently issued two new rules that significantly affect biologics and biosimilars.  The first rule spells out the naming conventions …

I-STOP Legislation “Hall Pass” Given to New York Health Care Community

By Poojah Babbrah, Practice Lead, PBM Services Providers, pharmacies and technology vendors in the state of New York are breathing a collective sigh of relief.  This afternoon, Governor Cuomo signed …